| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.15B | 27.29B | 27.26B | 27.07B | 28.09B | 25.28B |
| Gross Profit | 11.96B | 11.46B | 12.14B | 12.32B | 12.88B | 11.79B |
| EBITDA | 2.92B | 3.15B | 3.67B | 4.00B | 5.22B | 4.45B |
| Net Income | 547.00M | 2.15B | 1.35B | 1.84B | 2.49B | 1.86B |
Balance Sheet | ||||||
| Total Assets | 65.62B | 68.67B | 67.57B | 65.99B | 67.26B | 64.79B |
| Cash, Cash Equivalents and Short-Term Investments | 13.67B | 16.22B | 20.30B | 25.16B | 31.82B | 31.80B |
| Total Debt | 1.63B | 1.54B | 1.59B | 1.63B | 1.75B | 1.74B |
| Total Liabilities | 8.49B | 7.72B | 9.38B | 8.82B | 9.49B | 9.12B |
| Stockholders Equity | 57.12B | 60.93B | 58.17B | 57.16B | 57.76B | 55.66B |
Cash Flow | ||||||
| Free Cash Flow | -1.54B | -2.13B | -2.08B | -3.61B | 1.24B | 1.73B |
| Operating Cash Flow | 554.00M | 4.17B | 2.71B | 2.31B | 2.30B | 2.95B |
| Investing Cash Flow | -2.53B | -4.80B | -6.85B | -333.00M | 4.65B | 3.64B |
| Financing Cash Flow | -423.50M | -1.04B | -1.39B | -3.74B | -1.50B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.67B | 11.67 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥72.02B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
72 Outperform | ¥178.40B | 10.51 | 10.28% | 2.77% | 4.61% | 1.98% | |
67 Neutral | ¥183.15B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
66 Neutral | ¥30.11B | 14.14 | ― | 2.13% | 0.12% | 59.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.65B | 13.34 | ― | 3.09% | 7.43% | 47.68% |